Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | -5.33% | -17.49% | +6.34% |
May. 09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 166M 121M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.32M | Net income 2025 * | -47M -34.36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.6
x | P/E ratio 2025 * |
-3.71
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.97% |
Latest transcript on DiaMedica Therapeutics Inc.
1 day | +2.24% | ||
1 week | -8.86% | ||
Current month | +26.09% | ||
1 month | +31.28% | ||
3 months | +8.32% | ||
6 months | +36.32% | ||
Current year | +12.32% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Pauls
CEO | Chief Executive Officer | 52 | 05-03-31 |
Scott Kellen
DFI | Director of Finance/CFO | 59 | 18-03-31 |
Ambarish Shah
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Kuntz
BRD | Director/Board Member | 66 | 23-05-29 |
Tanya Lewis
BRD | Director/Board Member | 53 | 23-02-28 |
James Parsons
BRD | Director/Board Member | 58 | 10-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 3.02 | -5.33% | 24 131 |
24-05-13 | 3.19 | +2.24% | 18,196 |
24-05-10 | 3.12 | -4.00% | 22,577 |
24-05-09 | 3.25 | -6.34% | 74,346 |
24-05-08 | 3.47 | -5.19% | 102,314 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.32% | 121M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.45% | 21.93B | |
-12.15% | 22.34B | |
-5.34% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- DMAC Stock